Monsanto's 'Roundup Ready' Alfalfa Controversy
|
|
ICMR HOME | Case Studies Collection
Case Details:
Case Code : BECG078
Case Length : 13 Pages
Period : 1999-2007
Pub Date : 2007
Teaching Note :Not Available Organization : Monsanto Company
Industry : Agricultural Biotechnology
Countries : US
To download Monsanto's 'Roundup Ready' Alfalfa Controversy case study
(Case Code: BECG078) click on the button below, and select the case from the list of available cases:
OR
Buy With PayPal
|
Price:
For delivery in electronic format: Rs. 200; For delivery through Shipping & Handling Charges extra: Rs. 200 +Shipping & Handling Charges extra
»Business Ethics Case Studies »
Business Ethics Short Case Studies
» Short Case Studies
» View Detailed Pricing Info » How To Order This Case » Business Case Studies » Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
Chat with us
Please leave your feedback
|
<< Previous
Introduction Contd...
This view was also supported by several studies in the academic field and
examples in real life. For instance, Don Cameron (Cameron), a farmer based in
California, grew several organic and biotech crops which included organic
alfalfa as well as RRA. According to Cameron, "Proper stewardship makes it
possible to grow both organic and biotech crops. We've successfully accomplished
this for nearly a decade on our operation and plan to continue."8 Commenting on
the value proposition offered by RRA, Chris Peterson, Marketing Manager at
Monsanto, said, "With Roundup Ready Alfalfa system, growers will become familiar
with a system that will allow them to produce cleaner, more yield,
higher-quality alfalfa, and should realize an incremental earning opportunity
compared to the way that they grow alfalfa today."9
|
|
The RRA issue took center stage in February 2006 when CFS, along with some
other co-plaintiffs, filed a lawsuit against the USDA, claiming that it had
not undertaken a thorough investigation on the impact of RRA on public
health and its environmental and economic consequences. Commenting on the
May 3 final ruling, Jay Feldman, Executive Director, Beyond Pesticides10,
said, "This landmark decision curtails a genetically engineered crop that,
among other serious environmental problems, increases farmers' dependency on
toxic weed killers that hurt farmers, food consumers, and the environment."11
|
Background Note
In April 2000, Pharmacia & Upjohn Inc. (Pharmacia), a
US-Swedish drug company, completed a merger with Monsanto. The merged
entity was named Pharmacia Corporation. Pharmacia was attracted by the
success achieved by Monsanto's blockbuster drug, Celebrex, used for the
treatment of arthritis; it was not interested in Monsanto's agriculture
business. By the end of 2000, Pharmacia Corporation hived off the
agriculture division of Monsanto into a new company called Monsanto
Agriculture Company, which was later renamed Monsanto. Monsanto was
headquartered in St. Louis, Missouri... |
Excerpts
>>
|
|